Baxter Operating Expenses 2010-2024 | BAX
Baxter annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- Baxter operating expenses for the quarter ending September 30, 2024 were $2.544B, a 5.12% increase year-over-year.
- Baxter operating expenses for the twelve months ending September 30, 2024 were $14.848B, a 14.98% increase year-over-year.
- Baxter annual operating expenses for 2023 were $14.423B, a 13.89% decline from 2022.
- Baxter annual operating expenses for 2022 were $16.749B, a 55.14% increase from 2021.
- Baxter annual operating expenses for 2021 were $10.796B, a 7.35% increase from 2020.
| Baxter Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2023 | $14,423 |
| 2022 | $16,749 |
| 2021 | $10,796 |
| 2020 | $10,057 |
| 2019 | $9,590 |
| 2018 | $9,515 |
| 2017 | $9,296 |
| 2016 | $9,418 |
| 2015 | $9,519 |
| 2014 | $10,063 |
| 2013 | $8,917 |
| 2012 | $11,166 |
| 2011 | $10,947 |
| 2010 | $10,707 |
| 2009 | $9,685 |
| Baxter Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | $2,544 |
| 2024-06-30 | $4,004 |
| 2024-03-31 | $3,405 |
| 2023-12-31 | $4,895 |
| 2023-09-30 | $2,420 |
| 2023-06-30 | $3,724 |
| 2023-03-31 | $3,384 |
| 2022-12-31 | $3,386 |
| 2022-09-30 | $6,489 |
| 2022-06-30 | $3,330 |
| 2022-03-31 | $3,544 |
| 2021-12-31 | $2,853 |
| 2021-09-30 | $2,713 |
| 2021-06-30 | $2,674 |
| 2021-03-31 | $2,556 |
| 2020-12-31 | $2,775 |
| 2020-09-30 | $2,502 |
| 2020-06-30 | $2,387 |
| 2020-03-31 | $2,393 |
| 2019-12-31 | $2,503 |
| 2019-09-30 | $2,348 |
| 2019-06-30 | $2,484 |
| 2019-03-31 | $2,255 |
| 2018-12-31 | $2,433 |
| 2018-09-30 | $2,379 |
| 2018-06-30 | $2,458 |
| 2018-03-31 | $2,245 |
| 2017-12-31 | $2,509 |
| 2017-09-30 | $2,407 |
| 2017-06-30 | $2,258 |
| 2017-03-31 | $2,122 |
| 2016-12-31 | $2,342 |
| 2016-09-30 | $2,372 |
| 2016-06-30 | $2,517 |
| 2016-03-31 | $2,187 |
| 2015-12-31 | $2,425 |
| 2015-09-30 | $2,395 |
| 2015-06-30 | $2,388 |
| 2015-03-31 | $2,311 |
| 2014-12-31 | $2,598 |
| 2014-09-30 | $2,492 |
| 2014-06-30 | $3,495 |
| 2014-03-31 | $3,176 |
| 2013-12-31 | $3,776 |
| 2013-09-30 | $3,056 |
| 2013-06-30 | $2,841 |
| 2013-03-31 | $2,733 |
| 2012-12-31 | $2,976 |
| 2012-09-30 | $2,700 |
| 2012-06-30 | $2,795 |
| 2012-03-31 | $2,695 |
| 2011-12-31 | $2,969 |
| 2011-09-30 | $2,734 |
| 2011-06-30 | $2,705 |
| 2011-03-31 | $2,539 |
| 2010-12-31 | $2,975 |
| 2010-09-30 | $2,442 |
| 2010-06-30 | $2,496 |
| 2010-03-31 | $2,794 |
| 2009-12-31 | $2,737 |
| 2009-09-30 | $2,413 |
| 2009-06-30 | $2,376 |
| 2009-03-31 | $2,159 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.731B | $14.813B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.392B | 27.46 |
| Boston Scientific (BSX) | United States | $154.781B | 41.84 |
| Stryker (SYK) | United States | $150.988B | 32.49 |
| EssilorLuxottica (ESLOY) | France | $128.761B | 0.00 |
| Medtronic (MDT) | Ireland | $116.457B | 17.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.724B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
| Agilent Technologies (A) | United States | $42.120B | 27.91 |
| GE HealthCare Technologies (GEHC) | United States | $40.456B | 20.98 |
| ResMed (RMD) | United States | $34.834B | 26.83 |
| Terumo (TRUMY) | Japan | $27.701B | 39.39 |
| Koninklijke Philips (PHG) | Netherlands | $25.801B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.443B | 12.84 |
| Insulet (PODD) | United States | $20.179B | 80.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.039B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.951B | 37.15 |
| Bio-Rad Laboratories (BIO) | United States | $9.670B | 32.87 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.320B | 14.69 |
| Prestige Consumer Healthcare (PBH) | United States | $4.316B | 20.65 |
| ICU Medical (ICUI) | United States | $3.878B | 36.92 |
| Envista Holdings (NVST) | United States | $3.750B | 29.85 |
| Perrigo (PRGO) | Ireland | $3.407B | 10.03 |
| Haemonetics (HAE) | United States | $3.164B | 14.89 |
| GN Store Nord (GNNDY) | Denmark | $3.123B | 21.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.832B | 18.23 |
| Neogen (NEOG) | United States | $2.315B | 26.67 |
| LeMaitre Vascular (LMAT) | United States | $2.245B | 54.55 |
| AtriCure (ATRC) | United States | $1.997B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.513B | 26.48 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.29 |
| InMode (INMD) | Israel | $1.269B | 10.61 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.250B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.215B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.069B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 15.27 |
| Evolus (EOLS) | United States | $0.849B | 0.00 |
| CeriBell (CBLL) | United States | $0.810B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.21 |
| Capricor Therapeutics (CAPR) | United States | $0.652B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.627B | 27.14 |
| Valneva SE (VALN) | France | $0.563B | 0.00 |
| Omeros (OMER) | United States | $0.526B | 0.00 |
| SNDL (SNDL) | Canada | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.474B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.424B | 0.00 |
| ZimVie (ZIMV) | United States | $0.383B | 32.26 |
| Canopy Growth (CGC) | Canada | $0.363B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 62.50 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Quanterix (QTRX) | United States | $0.320B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
| Biote (BTMD) | United States | $0.261B | 5.73 |
| Zynex (ZYXI) | United States | $0.252B | 52.80 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 3.26 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.203B | 15.16 |
| Brainsway (BWAY) | Israel | $0.200B | 106.40 |
| MacroGenics (MGNX) | United States | $0.174B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.83 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 11.44 |
| Exagen (XGN) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| InterCure (INCR) | Israel | $0.080B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| INLIF (INLF) | $0.067B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.064B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.051B | 14.60 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |